Veterinary virologists get $3.7M grant for COVID researchAugust 30, 2021A five-year, $3.7-million grant supporting the research of a new COVID treatment has been issued to veterinary virologists at Kansas State University (K-State).
SPONSORED CONTENTHelping manage the hidden signs of stressOur therapeutic nutrition targets underlying stress in cats with GI or urinary issues — helping provide relief to pets and their humans. + Learn More
DVMs essential to future of biomedical researchAugust 13, 2020Utilizing the unique skill sets of veterinarians within the field of biomedical research is the focus of a postgraduate training program at the Virginia-Maryland College of Veterinary Medicine (VMCVM).
Penn Vet doctors receive NIH grant to target canine autoimmune diseaseOctober 4, 2018Nicola J. Mason, BVetMed, PhD, and Aimee S. Payne, MD, PhD, have received the National Institutes of Health (NIH) Director's Transformative Research Award, part of the institute's High-Risk, High-Reward Research program, for their work in targeting autoimmune disease in dogs. Under the grant, Drs. Mason and Payne are looking to evaluate a genetically engineered cell-based therapy to treat dogs with naturally occurring autoimmune skin disease known as pemphigus. Dogs are one of the few other species to develop pemphigus, a condition that mirrors pemphigus in human patients. Evaluation of this approach to treat pet dogs with the disease may ultimately lead to breakthrough therapies for humans. According to the Autoimmune Disease Research Center at Johns Hopkins, at least 10 million Americans suffer from the more than 80 illnesses caused by autoimmunity. "The successful treatment of autoimmunity in the family dog using this unique approach would not only be a breakthrough in veterinary medicine, but could also change the way autoimmune disease is treated in humans," said Mason, associate professor of medicine and pathobiology at the School of Veterinary Medicine at Penn Vet. "We believe that this work may facilitate the translation of cellular immunotherapies for a broad range of canine …
NIH awards UF veterinarian five-year grant to study canine diabetesAugust 24, 2018Allison O'Kell, DVM, a small animal internal medicine specialist and clinical assistant professor at the University of Florida College of Veterinary Medicine, has received a Mentored Clinical Scientist Research Career Development Award from the National Institutes of Health in support of her studies relating to canine diabetes. The five-year grant, known as a K08, will support Dr. O'Kell's career and research project. "The overall goal of my research is to study the causes of diabetes in the dog," O'Kell said. "We hope that the work will benefit dogs with this disease, but also to help us better understand whether studying the disease in dogs may be a novel way to understand the disease in humans." The disease has been increasing in prevalence over time in both dogs and humans, emphasizing the importance of research to determine the underlying causes of the disease as well as methods for prevention and treatment, she added. O'Kell's primary mentor is Mark Atkinson, PhD, the American Diabetes Association Eminent Scholar for Diabetes Research and Jeffrey Keene Family Professor in the UF College of Medicine. Atkinson also directs the UF Diabetes Institute and has been investigating human Type 1 diabetes for …
UA researchers get $4.8 million to develop valley fever vaccineSeptember 6, 2017The University of Arizona's (UA) efforts to prevent valley fever in dogs received a boost in the way of a $4.8 million, four-year grant from the National Institutes of Health, providing the funding necessary to get the disease's delta-CPS1 vaccine to market, according to John Galgiani, MD, director of the UA Valley Fever Center for Excellence and principal investigator of the NIH grant. The vaccine, which could hit the market as soon as five years from now, will be developed for dogs first, but the end goal is to use it in humans, as well, according to Dr. Galgiani. There is currently no prevention or cure for valley fever, which is potentially deadly in both humans and dogs. Every year, an estimated 30,000 people and 60,000 dogs in Arizona get sick from valley fever, also known as coccidioidomycosis, according to UA. The cocci fungus that causes the disease is found mainly in dusty areas of Arizona and California, and it contributed to the deaths of 54 people in Arizona last year, state officials said. Treatment for valley fever is expensive: $4 to $6 per-day meds, blood tests, and additional …
